Walk In interview for granules India [for Quality Control] on 17th August 2021

Walk In interview for granules India [for Quality Control] on 17th August 2021

Company Profile:

Granules India Limited is Indian pharmaceutical manufacturing company based in Hyderabad, Indian. Granules manufacturing several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets.

Walk-In Interviews for Quality Control (Formulations)  Granules India Pvt. Limited

Department: Quality Control (Formulation-OSD)

Qualification: M.Sc/ B.Pharm/ M.Pharm

Experience: 1-6 years

In process, Finished products, Raw Material, Packing Material, Stability. Tests: GC/HPLC/Dissolution/ UV,IR, swab analysis, Assay, RS, BA, BU, UOD, Dissolution & Residual solvents.

Location: Hyderabad

Time and Venue Details: Date : Walk-In Interview 17th August 2021 from 09:00 AM to 12:00 PM  at Granules India Limited Sy No. 160/A, 161/E, 162 & 174/A, Gagillapur Village, Dundigal- Gandimaisamma Mandal, Medchal- Malkajgiri  District – 500 043,Telangana,India

Contact No: Shilpa NVK -7995144462

Walk In interview for granules India [for Quality Control] on 17th August 2021

Granules India Ltd is a fast growing pharmaceutical supplier based in one of the most dynamic economies of the world, serving all major markets worldwide.

At Granules, we don’t just deliver products to our customers, but also provide business solutions, built on partnerships for mutual growth. From a small beginning dating back to 1984 and having reached to this level now at a fast pace, we are destined to grow larger and bigger.

                           FAQs

How to I know about opportunity for employment at Granules?

Visit our careers page frequently, which lists the present opportunities for various skillsets with varied experience in different functions. This page is updated as and when a new opportunity arises.

How to join granules?

Submit your resume in response to the openings listed in the Careers page.

What is granules recruitment process?

Our recruitment process includes various processes like cognitive testing, personality profiling, technical and behavioural interviews. Background checks also form part of the process.

What is it like to work at Granules?

Granules is a great place to work. We understand that shaping our organization means taking care of our employees and developing their skills to create business sustainability.

                        Milestones

In 1984, Triton Laboratories was formed to produce Paracetamol API at our Bonthapally facility in Hyderabad.

In 1987, Triton became the second Indian company to export pharmaceutical products to the U.S.

In 1990, Triton opened its second manufacturing facility at Jeedimetla to produce multiple APIs.

In 1991, Granules India Private Limited was incorporated.

In 1993, Granules establishedits first PFI facility at Jeedimetla.

In 1995, Granules became a listed company, after having initial public offerings on the Bombay and Hyderabad Stock Exchanges.

In 2003, Granules opened a new large volume PFI facility in Gagillapur.

In 2003, Granules setup a wholly owned subsidiary, Granules USA, for marketing in the US

In 2005, a new Paracetamol plant was built in Bonthapally, Hyderabad.

In 2006, Granules formed a joint venture with Hubei Biocause to make and sell Ibuprofen API.

In 2008, Granules entered into the Finished Dosage segment.

In 2010, Granules received US FDA approval for its first Abbreviated New Drug Application (ANDA).

In 2011, Granules-OmniChem, a joint venture with Ajinomoto OmniChem was established to venture into Contract Research and Manufacturing Services (CRAMS) business.

In 2013, Granules established a 10,000 sq. foot R&D facility in Pragathi Nagar, Hyderabad.

In 2014, Granules acquired Auctus Pharma

In 2014, Granules setup a wholly-owned subsidiary in the US; Granules Pharmaceutical to focus on formulation R&D.

In 2015, Granules entered the Over the Counter business in the US through Granules Consumer Healthcare.